• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4637632)   Today's Articles (4382)   Subscriber (50143)
For: Olsen A, Beall RF, Knox RP, Tu SS, Kesselheim AS, Feldman WB. Patents and regulatory exclusivities on FDA-approved insulin products: A longitudinal database study, 1986-2019. PLoS Med 2023;20:e1004309. [PMID: 37971985 PMCID: PMC10653475 DOI: 10.1371/journal.pmed.1004309] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/25/2022] [Accepted: 10/05/2023] [Indexed: 11/19/2023]  Open
Number Cited by Other Article(s)
1
Feldman R. Paucity of intellectual property rights information in the US biologics system a decade after passage of the Biosimilars Act. PLoS Med 2024;21:e1004381. [PMID: 38662775 PMCID: PMC11081489 DOI: 10.1371/journal.pmed.1004381] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Revised: 05/09/2024] [Indexed: 05/12/2024]  Open
2
Alhiary R, Gabriele S, Kesselheim AS, Tu SS, Feldman WB. Delivery Device Patents on GLP-1 Receptor Agonists. JAMA 2024;331:794-796. [PMID: 38315473 PMCID: PMC10845039 DOI: 10.1001/jama.2024.0919] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/26/2023] [Accepted: 01/22/2024] [Indexed: 02/07/2024]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA